Forecasting future prevalence of type 2 diabetes mellitus in Syria

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Al Ali, Radwan ^a,b   Mzayek, Fawaz ^a,c   Rastam, Samer ^a,b   M Fouad, Fouad ^a   O'Flaherty, Martin ^d   Capewell, Simon ^d   Maziak, Wasim ^a,e  

^a SYRIAN CENTER FOR TOBACCO STUDIES   (Syrian Arab Republic)

^b UNIVERSITY OF ALEPPO   (Syrian Arab Republic)

^c UNIVERSITY OF MEMPHIS   (United States)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; DIABETES MELLITUS, TYPE 2; ETHNIC GROUP; FEMALE; FORECASTING; HEALTH PROMOTION; HUMAN; MALE; MIDDLE AGED; PREVALENCE; PREVENTIVE HEALTH SERVICE; RISK FACTOR; SYRIAN ARAB REPUBLIC;

ADULT; AGE FACTORS; AGED; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; FEMALE; FORECASTING; HEALTH PROMOTION; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PREVENTIVE HEALTH SERVICES; RISK FACTORS; SYRIA;

EID: 84878004357     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-507     Document Type: Article

References (25)

1. Global burden of disease attributable to diabetes mellitus in Brazil. Oliveira AF, Valente JG, Leite Ida C, Schramm JM, Azevedo AS, Gadelha AM, Cad Saude Publica 2009 25 6 1234 1244 10.1590/S0102-311X2009000600006 19503954
2. International Diabetes Federation, IDF Diabetes Atlas Brussels, Belgium: International Diabetes Federation 5 2011 [ http://www.idf.org/diabetesatlas ]
3. Global estimates of the prevalence of diabetes for 2010 and 2030. Shaw JE, Sicree RA, Zimmet PZ, Diabetes Res Clin Pract 2010 87 1 4 14 10.1016/j.diabres.2009.10.007 19896746
4. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Wild S, Roglic G, Green A, Sicree R, King H, Diabetes Care 2004 27 5 1047 1053 10.2337/diacare.27.5.1047 15111519
5. Globalization of diabetes: the role of diet, lifestyle, and genes. Hu FB, Diabetes Care 2011 34 6 1249 1257 10.2337/dc11-0442 21617109
6. Mediterranean studies of cardiovascular disease and hyperglycemia: analytical modeling of population socio-economic transitions (MedCHAMPS)-rationale and methods. Maziak W, Critchley J, Zaman S, Unwin N, Capewell S, Bennett K, Unal B, Husseini A, Romdhane HB, Phillimore P, Int J Public Health 2012 [Epub ahead of print] 10.1007/s00038-012-0423-4
7. Project ftM: 018 Forecasting diabetes prevalence using a simple model: England and Wales 1993-2006. O'Flaherty M, Critchley J, Wild S, Unwin N, Capewell S, J Epidemiol Community Health 2010 64 Suppl 1 7
8. Kemeny JG, Snell JL, Finite Markov chains New York: Springer-Verlag 1983
9. Central Bureau of Statistics, Central Bureau of Statistics 2011 http://www.cbssyr.org/index-EN.htm
10. United Nations, Department of economics and social affairs 2011 [ http://www.un.org/esa/population/ ]. Accessed on 27 January 2011
11. World Health Organization, Noncommunicable diseases. STEPwise surveillance. Syrian Arab Republic Report 2003 http://www.who.int/chp/steps/ SyrianArabRepublicSTEPSReport
12. National, regional, and global trends in adult overweight and obesity prevalences. Stevens GA, Singh GM, Lu Y, Danaei G, Lin JK, Finucane MM, Bahalim AN, McIntire RK, Gutierrez HR, Cowan M, et al. Population health metrics 2012 10 1 22 10.1186/1478-7954-10-22 23167948
13. Trends and stabilization up to 2022 in overweight and obesity in Switzerland, comparison to France, UK, US and Australia. Schneider H, Dietrich ES, Venetz WP, Int J Environ Res Public Health 2010 7 2 460 472 10.3390/ijerph7020460 20616985
14. A generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Barendregt JJ, Van Oortmarssen GJ, Vos T, Murray CJ, Population health metrics 2003 1 1 4 10.1186/1478-7954-1-4 12773212
15. World Health Organization, Health statistics and health information systems. Global Burden of Disease (GBD) 2012 Avalable at http://www.who.int/ healthinfo/global-burden-disease/tools-software/en/
16. An indirect estimate of the incidence of non-insulin-dependent diabetes mellitus. Barendregt JJ, Baan CA, Bonneux L, Epidemiology 2000 11 3 274 279 10.1097/00001648-200005000-00008 10784243
17. The Verona diabetes study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality. Muggeo M, Verlato G, Bonora E, Bressan F, Girotto S, Corbellini M, Gemma ML, Moghetti P, Zenere M, Cacciatori V, et al. Diabetologia 1995 38 3 318 325 10.1007/BF00400637 7758879
18. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J, JAMA 2007 298 22 2654 2664 10.1001/jama.298.22.2654 18073361
19. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH, BMC Publ Health 2009 9 88 10.1186/1471-2458-9-88
20. The International Diabetes Federation diabetes atlas methodology for estimating global and national prevalence of diabetes in adults. Guariguata L, Whiting D, Weil C, Unwin N, Diabetes Res Clin Pract 2011 94 3 322 332 10.1016/j.diabres.2011.10.040 22100977
21. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB, JAMA 2009 301 20 2129 2140 10.1001/jama.2009.726 19470990
22. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. King H, Aubert RE, Herman WH, Diabetes Care 1998 21 9 1414 1431 10.2337/diacare.21.9.1414 9727886
23. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults.WHO Ad Hoc diabetes reporting group. King H, Rewers M, Diabetes Care 1993 16 1 157 177 10.2337/diacare.16.1.157 8123057
24. Epidemiology of Type 2 diabetes mellitus in Aleppo. Syria. Albache N, Al Ali R, Rastam S, Fouad FM, Mzayek F, Maziak W, J Diabetes 2010 2 2 85 91 20923489
25. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, et al. Lancet 2011 377 9765 557 567 10.1016/S0140-6736(10)62037-5 21295846